Literature DB >> 35618921

Amino acid-balanced diets improved DSS-induced colitis by alleviating inflammation and regulating gut microbiota.

Sen Li1,2, Shuya Yang1,2, Yu Zhang1,2, Kai Huang1,2, Ting Liang1,2, Yu Chen1,2, Yingjie Guan1,2, Ruizhi Shang1,2, Tong Guan1,2, Jiang Wu3, Yingwei Chen4, Xiao Guan5,6.   

Abstract

PURPOSE: Inflammatory bowel disease (IBD) is a multifactorial chronic disease of the gastrointestinal tract. Dietary intervention in the treatment of IBD has gradually attracted more attention. In this study, amino acid-balanced diets (AABD) based on grains were developed and their influences on the regulation of IBD were investigated.
METHODS: Dextran sodium sulfate (DSS)-induced acute colitis mice model was employed to evaluate the effects of AABD. Pathological symptoms, intestinal inflammation, gut barrier proteins and gut microbiota were determined after AABD intake.
RESULTS: It was shown that AABD alleviated the symptoms of colitis by reducing the histological scores of mice colon, suppressing the expression of pro-inflammatory cytokines (IL-1β, IL-6 and TNF-α) and upregulating the expression of tight junction proteins. Analysis of gut microbiota revealed that AABD altered the structure of gut microbiota by decreasing the abundance and richness of harmful bacteria induced by DSS (Escherichia-Shigella, Parasutterella, etc.) and increasing that of beneficial bacteria (Akkermansia, etc.). Correlation analysis indicated that the alterations of pro-inflammatory factors were related with the change of microbiota, suggesting that the inhibitory effects of AABD on inflammation might be due to its regulation gut microbiota.
CONCLUSION: The AABD could efficiently mitigate colitis, and this study indicated that AABD could be applied as a promising dietary regulation strategy of IBD.
© 2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany.

Entities:  

Keywords:  Amino acid-balanced diets; Colitis; Grains; Gut microbiota; Inflammatory cytokines

Mesh:

Substances:

Year:  2022        PMID: 35618921     DOI: 10.1007/s00394-022-02906-y

Source DB:  PubMed          Journal:  Eur J Nutr        ISSN: 1436-6207            Impact factor:   4.865


  26 in total

Review 1.  Immunopathogenesis of IBD: current state of the art.

Authors:  Heitor S P de Souza; Claudio Fiocchi
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2015-12-02       Impact factor: 46.802

2.  Inhibition of ulcerative colitis in mice after oral administration of a polyphenol-enriched cocoa extract is mediated by the inhibition of STAT1 and STAT3 phosphorylation in colon cells.

Authors:  Isabel Andújar; M Carmen Recio; Rosa M Giner; Elena Cienfuegos-Jovellanos; Sara Laghi; Begoña Muguerza; José Luis Ríos
Journal:  J Agric Food Chem       Date:  2011-05-31       Impact factor: 5.279

Review 3.  The role of the gut microbiota in the treatment of inflammatory bowel diseases.

Authors:  Ioanna Aggeletopoulou; Christos Konstantakis; Stelios F Assimakopoulos; Christos Triantos
Journal:  Microb Pathog       Date:  2019-10-03       Impact factor: 3.738

4.  Camellia sinensis and Litsea coreana Ameliorate Intestinal Inflammation and Modulate Gut Microbiota in Dextran Sulfate Sodium-Induced Colitis Mice.

Authors:  Yan Liu; Xinghua Wang; Qiubing Chen; Liyong Luo; Mengjun Ma; Bo Xiao; Liang Zeng
Journal:  Mol Nutr Food Res       Date:  2020-02-17       Impact factor: 5.914

5.  Ficus carica polysaccharide attenuates DSS-induced ulcerative colitis in C57BL/6 mice.

Authors:  Qianhui Zou; Xin Zhang; Xiaoshuang Liu; Yitong Li; Qiaoli Tan; Qin Dan; Tian Yuan; Xuebo Liu; Rui Hai Liu; Zhigang Liu
Journal:  Food Funct       Date:  2020-07-13       Impact factor: 5.396

6.  Treatment of Active Crohn's Disease With an Ordinary Food-based Diet That Replicates Exclusive Enteral Nutrition.

Authors:  Vaios Svolos; Richard Hansen; Ben Nichols; Christopher Quince; Umer Z Ijaz; Rodanthi T Papadopoulou; Christine A Edwards; David Watson; Adel Alghamdi; Asker Brejnrod; Cecilia Ansalone; Hazel Duncan; Lisa Gervais; Rachel Tayler; Jonathan Salmond; Daniele Bolognini; Robert Klopfleisch; Daniel R Gaya; Simon Milling; Richard K Russell; Konstantinos Gerasimidis
Journal:  Gastroenterology       Date:  2018-12-11       Impact factor: 22.682

7.  Ginsenoside metabolite compound K promotes recovery of dextran sulfate sodium-induced colitis and inhibits inflammatory responses by suppressing NF-κB activation.

Authors:  Juan Li; Wei Zhong; Weiwei Wang; Shaoping Hu; Jiahui Yuan; Bing Zhang; Tianhui Hu; Gang Song
Journal:  PLoS One       Date:  2014-02-04       Impact factor: 3.240

8.  Gut microbiome structure and metabolic activity in inflammatory bowel disease.

Authors:  Eric A Franzosa; Alexandra Sirota-Madi; Julian Avila-Pacheco; Nadine Fornelos; Henry J Haiser; Stefan Reinker; Tommi Vatanen; A Brantley Hall; Himel Mallick; Lauren J McIver; Jenny S Sauk; Robin G Wilson; Betsy W Stevens; Justin M Scott; Kerry Pierce; Amy A Deik; Kevin Bullock; Floris Imhann; Jeffrey A Porter; Alexandra Zhernakova; Jingyuan Fu; Rinse K Weersma; Cisca Wijmenga; Clary B Clish; Hera Vlamakis; Curtis Huttenhower; Ramnik J Xavier
Journal:  Nat Microbiol       Date:  2018-12-10       Impact factor: 17.745

9.  ACE2 links amino acid malnutrition to microbial ecology and intestinal inflammation.

Authors:  Tatsuo Hashimoto; Thomas Perlot; Ateequr Rehman; Jean Trichereau; Hiroaki Ishiguro; Magdalena Paolino; Verena Sigl; Toshikatsu Hanada; Reiko Hanada; Simone Lipinski; Birgit Wild; Simone M R Camargo; Dustin Singer; Andreas Richter; Keiji Kuba; Akiyoshi Fukamizu; Stefan Schreiber; Hans Clevers; Francois Verrey; Philip Rosenstiel; Josef M Penninger
Journal:  Nature       Date:  2012-07-25       Impact factor: 49.962

10.  Elemental Diet Enriched with Amino Acids Alleviates Mucosal Inflammatory Response and Prevents Colonic Epithelial Barrier Dysfunction in Mice with DSS-Induced Chronic Colitis.

Authors:  Di Guo; Jun Yang; Fangmei Ling; Lei Tu; Junrong Li; Yidong Chen; Kaifang Zou; Liangru Zhu; Xiaohua Hou
Journal:  J Immunol Res       Date:  2020-08-14       Impact factor: 4.818

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.